56 results
Page 2 of 3
8-K
EX-99.1
c6ozn2 n4bt
10 Feb 20
Millendo Therapeutics Appoints Christophe Arbet-Engels, MD, PhD, as Chief Medical Officer
8:42am
8-K
EX-99.1
1g1b4qqo
13 Jan 20
Results of Operations and Financial Condition
6:03am
8-K
EX-99.1
0pm2zibx
22 Mar 19
Presentation to Lorem Ipsum Dolor May 2018 Corporate Presentation March 2019
5:14pm
8-K
EX-99.1
4nsibmoq5amk ea9n
7 Jan 19
Presentation to Lorem Ipsum Dolor May 2018 Corporate Presentation January 2019
8:54am
DEFM14A
kq4euf4w
6 Nov 18
Proxy related to merger
12:00am
424B3
otxr2pt
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
l7xu zb3hxd6
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-99.3
vo0yanp0zu0msnsdt
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-99.3
npwlr9e nwsz8rp30
9 Aug 18
Business combination disclosure
5:17pm